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Abstract
Background: Neuroendocrine cells (NECs) reside adjacent to colonic stem cells (SCs) in the crypt stem cell (SC)
niche, but how NECs are involved in regulation of SCs is unclear. We investigated NECs expressing somatostatin
(SST) and somatostatin receptor type 1 (SSTR1) because SST inhibits intestinal proliferation. Hypothesis: SSTR1 cells
maintain SCs in a quiescent state, and aberrant SST signaling contributes to SC overpopulation in colorectal cancer
(CRC).
Methods: The proportion of SCs to NECs cells was quantified, by flow cytometry, in CRC cell lines and primary
normal/tumor tissues based on cellular ALDH and SSTR1 levels, respectively. Doubling time and sphere-formation
was used to evaluate cell proliferation and stemness. CRC cell lines were treated with exogenous SST and SST
inhibitor cyclosomatostatin (cycloSST) and analyzed for changes in SCs and growth rate. Paracrine signaling
between NECs and SCs was ascertained using transwell cultures of ALDH+ and SSTR1+ cells.
Results: In CRC cell lines, the proportion of ALDH+ cells inversely correlates with proportion of SSTR1+ cells and
with rate of proliferation and sphere-formation. While primary normal tissue shows SST and SSTR1 expression, CRC
shows only SSTR1 expression. Moreover, ALDH+ cells did not show SST or SSTR1 expression. Exogenous SST
suppressed proliferation but not ALDH+ population size or viability. Inhibition of SSTR1 signaling, via cycloSST
treatment, decreased cell proliferation, ALDH+ cell population size and sphere-formation. When co-cultured with
SSTR1+ cells, sphere-formation and cell proliferation of ALDH+ cells was inhibited.
Conclusion: That each CRC cell line has a unique ALDH+/SSTR1+ ratio which correlates with its growth dynamics,
suggests feedback mechanisms exist between SCs and NECs that contribute to regulation of SCs. The growth
suppression by both SST and cycloSST treatments suggests that SST signaling modulates this feedback mechanism.
The ability of SSTR1+ cells to decrease sphere formation and proliferation of ALDH+ cells in transwell cultures
indicates that the ALDH subpopulation is regulated by SSTR1 via a paracrine mechanism. Since ALDH+ cells lack
SST and SSTR1 expression, we conjecture that SST signaling controls the rate of NEC maturation as SCs mature
along the NEC lineage, which contributes to quiescence of SCs and inhibition of proliferation.
Background
In colorectal cancer (CRC) development, the overpopu-
lation of neoplastic stem cells (SCs) appears to drive
tumor initiation and progression, but it is not really
known which specific mechanisms that regulate normal
colonic SCs, when dysregulated, result in SC overpopu-
lation in CRC [1–4]. We surmised that the interactions
and communication between different cell types within
the colonic crypt SC niche may be crucial to regulation
of normal SCs. Specific types of neuroendocrine cells
(NECs), such as somatostatin receptor 1 cells (SSTR1),
have been shown to reside in close proximity to colonic
SCs in the niche at the bottom of the normal human co-
lonic crypt (see Additional file 1: Figure S1). NECs are
known to function in inhibition and/or enhancement of
cell proliferation either by paracrine or autocrine
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signaling [5–8]. Nonetheless, the mechanisms through
which SCs and specific NECs interact with each other in
the normal colon have not been extensively studied. We
hypothesize that SSTR1 cells maintain colonic SCs in a
quiescent state, and aberrant SST signaling contributes
to SC overpopulation in CRC.
Indeed, a substantial body of evidence reveals that
various types of NECs are located along the normal in-
testinal tract and each NEC subtype has a different effect
on neighboring cells [6, 7, 9, 10]. Specific NEC functions
include secretion of peptides to act in a paracrine or
autocrine fashion to exert local effects on cell prolifera-
tion and differentiation, or exert distant effects by endo-
crine secretion [7]. These NECs are often selectively
located within the SC niche where the colonic SCs res-
ide in a quiescent state. Thus, the niche likely provides
the cues underlying slow-cycling dynamics of the SC
population and asymmetric SC division that maintains
the hierarchical nature of differentiated cell lineages in
the colonic crypt [2]. Of note, colonic NECs do not
appear to follow the classical hierarchical model of SC
differentiation and are thought to arise by direct differ-
entiation of a colonic SC, again supporting the close in-
teractions between the two cell types [8]. Consequently,
it seems feasible that the communication between NECs
and colonic SCs is crucial to normal crypt homeostasis
and maintenance of the quiescent nature of colonic SCs,
and that dysregulation of the interactions and communi-
cation between the cell types could lead to colonic SC
overpopulation during CRC progression.
To investigate possible regulatory mechanisms it must
be technically feasible to identify, track and isolate human
colonic SCs. Among various SC markers available, we
have found that aldehyde dehydrogenase (ALDH) serves
as a reliable and specific marker for normal and malignant
colonic SCs [11–14]. Consequently, we used the ALDE-
FLUOR assay in this study to identify the ALDH+ colonic
SCs and CSCs populations. For example, our previous
study showed that ALDH+ cells are localized to the bot-
tom of the colonic crypt and during progression from nor-
mal to adenoma, the number of ALDH+ cells increases
supporting the concept that SC overpopulation leads to
colon tumor development [11]. In our study [11] other SC
markers such as CD133 and CD44 were compared to
ALDH and we found that ALDH is the most specific
marker for identification of human colon SCs [11]. In our
current study we also used in vitro approaches including
transwell co-cultures to ascertain the effects of SSTR1 sig-
naling on ALDH+ cells. Our goal was to investigate how
SSTR1 cell signaling contributes to changes to the ALDH
+ cell population size and whether or not this regulation
is by a paracrine mechanism. To our knowledge, this is
the first attempt of looking at the effects of SSTR1 cell sig-
naling directly on the ALDH+ population.
Methods
Cell culture
HT29 cells obtained from American Type Culture Col-
lection (ATCC; Manassas, VA) were grown in monolayer
cultures and maintained in: McCoys medium (GIBCO/
Life Technologies) supplemented with 5% fetal bovine
serum (FBS) and 100 units/ml penicillin and 100ug/ml
streptomycin (P/S). SW480 cells obtained from ATCC
were maintained in Leibovitz’s 15 (L-15) medium
(GIBCO/Life Technologies) supplemented with 5% FBS
and P/S. LoVo, DiFi and COLO320 cells were main-
tained in Roswell Park Memorial Institute (RPMI-1640)
medium (GIBCO/Life Technologies) supplemented with
5% FBS and P/S. LoVo and DiFi cells were grown in
monolayer cultures, while COLO320 cells were grown in
suspension. DiFi and COLO320 cells were used as con-
trols to verify NE cell marker expression and slow cell
growth, as these cell lines contain high levels of NE posi-
tive cells [15, 16]. Since DiFi cells grow in monolayer
cultures, this cell line was used in Fig. 3 for comparison
to the other CRC cell lines for cell proliferation, and the
COLO320 cells were used in Fig. 1 for positive identifi-
cation of NE markers. COLO320 cells are reported to
express high percentages of cells that secrete NE-like
factors like serotonin, PTH, ACTH and other polypep-
tide hormones that are characteristics common to NE
cells [15]. All cell cultures were maintained at 37°C in
humidified air at 5% CO2.
ALDEFLUOR assay
Protocol was followed according to the manufacturer
(STEMCELL Technologies). Briefly, cells were grown to
80% confluence and lifted using 0.25% Trypsin-EDTA
(Fisher Scientific). Cells were resuspended in ALDE-
FLUOR assay buffer at a concentration of one million
cells/ml; to the control tube, 5 μl of the DEAB inhibitor
was added and to the sample tube, 5 μl of the activated
ALDEFLUOR reagent was added, mixed and immedi-
ately 500 μl of the suspension was taken out and put in
the control tube with the inhibitor. Cells were incubated
for 40 min at 37° C. After incubation, cells were spun
for five minutes to pellet and washed once with
ALDEFLUOR buffer. Cell were resuspended in 500 μl
ALDEFLUOR buffer and passed through a BD round
bottom tube with a 50 μm cell strainer (BD Biosciences).
Samples were placed on ice and covered from light
until ready for analysis on the BD FACSAria II Flow
Cytometer.
Flow cytometry
All cells were grown to 70–80% confluence and lifted
using an EDTA based solution called Cell Stripper
(Fisher Scientific). Cells were spun for five minutes to
pellet and resuspended in RPMI-1640 with either the
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SSTR1 antibody (Advanced Targeting System) at a 1:
100 dilution or rabbit IgM control at an equal con-
centration to the antibody. Cells were incubated on
ice for one hour. Following primary antibody and
IgM incubation, cells were washed twice with PBS,
and then incubated in the appropriate secondary
antibody at a concentration of 1:200 for one hour on
ice. Cells were washed twice and resuspended in 500
μl of RPMI-1640 medium and passed through a BD
round bottom tube with a 50 μm cell strainer (BD
Biosciences). Cell surface staining was analyzed using
the BD FACSCalibur and BD FACSAria II Flow
Cytometer. For our co-staining analysis, we chose to
use FITC and APC as our fluorophores because the
spectral overlap between these two fluorophores is
minimal [17].
Crypt isolation from normal colon tissue and
tumor colon tissue dissociation
Human tissues approval
Our research involving human colonic tissue was per-
formed in accordance with the Declaration of Helsinki
and was approved by the appropriate Institutional Re-
view Board (FWA00006557) at Christiana Care Health
Services, Inc (Newark, DE).
Normal tissue
Crypt Isolation –The mucosa layer was dissected from
the tissue and excess connective tissue, muscle and fat
were trimmed off. Mucosa layer was washed with PBS
(calcium and magnesium free) three times and then in-
cubate tissue in 3 mM EDTA (pH = 8) that has 0.5 mM
dithiothreitol (DTT) for 30 min on ice. After 30 min, the
Fig. 1 Differential expression pattern of ALDH and SSTR1 in colon cancer cell lines and patient tissue samples identifies unique populations of
cells. a Percent positive ALDH and SSTR1 cells in various colon cancer cell lines. ALDH analysis was performed using ALDEFLUOR assay, and SSTR1
cell surface staining was determined against the appropriate IgM control. The proportions of ALDH/SSTR1 positive cells is shown in the table.
Data represents mean ± S.E.M. (N = 3). b Representative dot plots of SSTR1 and ALDH expression analysis of SW480 cells and HT29 cells. c
Representative dot plots of one matched patient colon normal and tumor tissue sample to show the expression analysis of ALDH and SSTR1
cells. Matched normal and tumor tissue samples were obtained and processed as described in the Materials and Methods section. All samples
were run on the FACSAria II Flow Cytometer. Q = quadrant number, FITC channel detects ALDH positive cells using ALDEFLUOR assay, and APC
channel detects SSTR1 positive The values in the table are averages ± SD; N = 4 matched patient samples
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tube was shaken vigorously and checked for crypts.
Crypts were collected in a separate tube and tissue was
further incubated with fresh EDTA-DTT solution for an-
other 30–60 min. Again, the tube was shaken vigorously
for 5 min and isolated crypts were pooled in one tube.
Crypts were spun down at 500 rpm for 5 min, washed
two times with PBS, and pelleted again. Isolated crypts
were incubated in 1 mg/ml collagenase IV (Worthing-
ton) in HBSS (Hanks Balanced Salt Solution) containing
100 units/ml DNase I for 60–90 min. The cell suspen-
sion was passed through 70 μm and 40 μm filters (Par-
tec), and cells were re-spun. After washing twice with
PBS, the final single cell suspension was analyzed using
the ALDEFLUOR assay and Propidium Iodide (PI) at a
dilution of 1:20. All cells were passed through a BD
round bottom tube with a 50 μm cell strainer (BD Bio-
sciences) and then a 20 μm filter (Partec) before samples
were run on the BD FACSAria II Flow Cytometer.
Tumor tissue
Tumor tissue was washed three times with PBS, minced
into tiny 1mm pieces, and cut tissue was put in 1x colla-
genase/hyaluronidase (STEMCELL Technologies) and
100 units/ml DNaseI in HBSS and incubated for 60–90
min at 37° C. Cells were pelleted and passed through a
70 μm filter. Pelleted cells were incubated in red blood
cell (RBC) buffer (NH4Cl, KHCO3, 5% EDTA solution)
for 5 min on ice. Cells were washed twice with PBS and
analyzed by ALDEFLUOR assay and APC conjugated
EpCAM antibody at a dilution of 1:100 (Cell Signaling).
All cells were passed through a BD round bottom tube
with a 50 μm cell strainer (BD Biosciences) and then a
30 μm filter (Partec) before samples were run on the BD
FACSAria II Flow Cytometer.
Reverse transcriptase-polymerase chain reaction
RNA was collected from HT29 and SW480 cells when
they were 80% confluent. RNA was harvested using the
TRIzol method (Invitrogen). RNA was treated with
DNaseI using the DNA-free DNA Removal Kit
(Ambion) and the concentration of RNA was deter-
mined using the TECAN Infinite 200 PRO microplate
reader. cDNA was created using the SuperScript III
First-Strand Synthesis System (Life Technologies). Six
sets of primers were used for the RT-PCR: somatostatin,
SSTR1, SSTR2, SSTR3, SSTR4, and SSTR5. Primers
were obtained from a previously published article [18].
For each sample 100ng of cDNA was used. Products
were run on a 1.5% agarose gel with ethidium bromide
and imaged using the Syngene imaging system.
Cell proliferation
All cells were plated at a concentration of 20,000 cells/
well of a 24 well plate (four wells per cell line). Medium
was replaced every other day. Cells were detached using
0.25% Trypsin-EDTA at days 1, 3 and 5, and counted
with a hemocytometer. Cells were mixed in a 1:1 ratio
with Trypan blue (Fisher Scientific) so reported cell
counts include only viable cells. This was repeated three
times and the average values were graphed.
Soft agar assay
Two percent agar and culture medium (depending on
the cell line) containing 5% FBS were mixed in a 1:1 ra-
tio, yielding a final concentration of 1% agar. This layer
was poured into each well of a 24 well plate (Griener)
and allowed to solidify. A second layer containing 0.25%
agar in culture medium with 5,000 cells/well was poured
over the first layer of agar and allowed to solidify. When
the second layer solidified, culture medium was added to
each well. Medium was changed every two days and cul-
tures were allowed to grow for two weeks before being
fixed and stained with 0.05% crystal violet and then visu-
alized on a phase microscope.
Somatostatin treatment
HT29 and SW480 cells were treated with somatostatin
(500nM) (Tocris). This concentration was determined
from the dose response curve (Additional file 2: Figure
S2). Cells were plated at a concentration of 100,000
cells/well of a 6 well plate, in triplicate, and allowed to
attach overnight. Cells were serum starved for 24 h in
McCoy’s medium or L-15. Somatostatin was diluted in
fresh medium and added to the cells for 48 h following
serum starvation unless stated otherwise. All cells re-
ceived somatostatin and in the corresponding control
cells, an equal volume of vehicle was added.
Cyclosomatostatin treatment
HT29 and SW480 cells were treated with 10 uM cyclo-
somatostatin (Tocris), which is within the accepted con-
centration range used to inhibit SST signaling without
affecting cell viability [19]. Cells were plated at a concen-
tration of 100,000 cells/per well of a 6 well plate, in trip-
licate, and allowed to attach overnight. Cells were serum
starved for 24 h in McCoy’s medium (HT29) or L-15
medium (SW480). Cyclosomatostatin was diluted in
fresh medium and added to the cells for 48 h following
serum starvation. All experimental cells received cyclo-
somatostatin and the corresponding control cells, an
equal volume of vehicle (culture medium) was added.
Colonosphere assay
Cells were plated at a cell density of 200 cells per 100 μl
of stem cell media which is composed of serum free
DMEM/F12 (GIBCO Inc.) with the addition of Epider-
mal Growth Factor (EGF) and basic Fibroblast Growth
Factor (bFGF) and B-27 complex without Vitamin A
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(Life Technologies, Carlsbad, CA). The method and cul-
ture medium used to perform the colonosphere assay
was from a previously published article [20]. Low attach-
ment plates were used for this assay and colonospheres
were analyzed for their size (diameter) and numbers per
well on day ten using the 10x objective of a phase con-
trast microscope.
Co-culture of ALDH+ cells with SSTR1+ cells in culture
dishes
To evaluate the effect of SSTR1+ cell signaling on
ALDH+ cells, both of these cell subtypes were sorted
from HT29 and SW480 cells and co-cultured in ultra-
low attachment dishes with transwell inserts (0.4 um).
The use of culture inserts allowed for the ALDH+ and
SSTR1+ cells to be co-cultured without having cell-cell
contact in order to study paracrine signaling. After
ALDH+ and SSTR1+ cells were sorted on the BD FAC-
SAria II Flow Cytometer, they were plated under differ-
ent culture conditions. ALDH+ cells were plated in the
bottom chamber with or without SSTR1+ cells in the
top chamber and with or without the addition of ex-
ogenous SST. The effect of SSTR1+ cell signaling on
ALDH+ cells was assessed by sphere formation.
Statistics
All statistics were performed using Student’s t-test using
Microsoft excel or one- way ANOVA using Graph Pad
Prism software analysis.
Results
Quantification of ALDH+ and SSTR1+ cells in CRC cell
lines
Five different human CRC cell lines were screened and
each line showed a unique proportion of ALDH+ and
SSTR1+ cells that was constantly maintained over time
and upon multiple passages (Fig. 1a and Additional file
3: Figure S3). SW480 had the highest percent of ALDH+
cells, while the HT29 cell line had the lowest percentage.
The COLO320 cell line contained the highest percentage
of SSTR1+ cells, and HT29 and LoVo had the next high-
est percent of SSTR1+ cells. Based on these results, we
used the ALDH+ to SSTR1+ quotient as a marker and
measurable variable for the different CRC cell lines
(Fig. 1a). The CRC cell line (SW480) had a high ratio
value (~7.0) and three lines (LoVo, COLO320 & HT29)
had low values (<1.0). Thus, based on the proportion of
NECs, the relative proportion of CSCs varies among the
different cell lines analyzed. These findings suggest that
the proportion of SSTR1+ is inversely correlated to the
proportion of ALDH+ cells.
To further characterize the subpopulations of ALDH+
and SSTR1+ cells, several other tests were performed on
SW480 and HT29 lines. First, we wanted to rule out the
possibility that some ALDH+ cells might also express
SSTR1. Using double flow cytometric selection employ-
ing ALDEFLUOR assay with SSTR1 immunostaining, we
found that the percentage of cells that co-stained for
ALDH and SSTR1 was minimal. For example, the
SW480 and HT29 cell lines showed that only 0.1% of
cells co-expressed ALDH and SSTR1 (Fig. 1b).
Correlation between CRC cell lines and matched human
normal & malignant colon tissue
To see how the proportions of SSTR1 and ALDH in
CRC cell lines compare to fresh human CRCs, matching
normal and tumor colon tissue samples were collected
from surgery patients. Tissues were then dissociated into
single cells and analyzed by flow cytometry for ALDH
and SSTR1. Figure 1c shows a representative histogram
of a matched colon normal and tumor tissue sample pair
to show the percentages of ALDH+ and SSTR1+ cells.
Results on matched human patient sample pairs showed
that the proportions of ALDH+ and SSTR1+ cells were
in the same range of values as found for the CRC cell
lines (Fig. 1b-c). Human colon tissues were also assessed
for the proportion of cells that co-express ALDH and
SSTR1 and the same low percentage of co-staining cells
was seen as was observed in the CRC cell lines (Fig. 1c).
Expression of somatostatin signaling components
in CRC cell lines and fresh human colon tissues
We determined, by conventional RT-PCR, if somato-
statin (SST) and its receptors (SSTR1-5) are expressed
in SW480 and HT29 cells as well as in matched fresh
normal and tumor human colon tissue samples. Results
on CRC lines showed that both HT29 and SW480 cells
express SST, SSTR1, SSTR2, and SSTR4, but the tran-
script level is more abundant in HT29 cells than SW480
cells (Fig. 2a). These results on SSTR1 transcript level
concur with the encoded protein receptor levels.
Samples were also collected from patients and tissues
were dissociated into single cells. RNA was isolated from
the samples and the mRNA expression of SST and its re-
ceptors was analyzed using conventional RT-PCR. In
matched fresh colon samples, a notable difference was
observed in expression of somatostatin between normal
and cancer. While all normal samples expressed SST,
SST expression was absent in all matched tumor sam-
ples. SSTR1 was present in all normal samples and in 3
out of 5 tumor samples (Fig. 2b). Results were compar-
able between the CRC cell lines and analysis on human
patient CRC samples (Fig. 2a-b).
We then determined, by RT-PCR, if somatostatin and
its receptors are expressed in ALDH+ and ALDH- cells
isolated from HT29 and SW480 lines. ALDH- cells from
the HT29 line expressed SST, SSTR1, SSTR2, and
SSTR4, while the sorted ALDH+ cells did not express
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SST or any of its receptors (Fig. 2c). Similarly, ALDH-
cells from SW480 expressed SSTR1 (low), SSTR2, and
SSTR4, while the ALDH+ cells did not express SST or
any of its receptors (Fig. 2c). Overall, these findings
suggest that at the mRNA and protein level, there is no
appreciable expression of SST or SSTR1 in the ALDH+
cells from either HT29 or SW480 CRC cell lines.
Proliferation rate inversely correlates with ALDH/
SSTR1 quotient for CRC cell lines
Because there was such a difference among cell lines in
the proportion of ALDH vs SSTR1, we determined if the
growth properties of these cells differed in vitro. In the
CRC lines tested, the proportion of ALDH+ cells in-
versely correlates with proportion of SSTR1+ cells and
with rate of proliferation. For example, HT29 cells (hav-
ing a low ALDH/SSTR1 quotient) had the fastest growth
rate, while the SW480 cells (having a high ALDH/SSTR1
quotient) had the slowest growth rate (Fig. 3a). Indeed,
the doubling time for these two cell lines was 2.5 days
for the HT29 cells and 4 days for the SW480 cells. Thus,
the proliferation rate appears to inversely correlate with
the ALDH/SSTR1 quotient.
HT29 and SW480 CRC cell lines possess different
degrees of self-renewal based on sphere-forming
ability
One important characteristic of SCs is their ability to
self-renew and give rise to more SCs or progenitor cells.
From the data just presented, HT29 cells contain a low
percentage of stem-like ALDH+ cells and high percent-
age of SSTR1+ cells, while the SW480 cell line contains
a higher percentage of ALDH+ cells, but lower percent-
age of SSTR1+ cells (Fig. 1a). To test these cells for the
SC property of self-renewal we evaluated their sphere-
forming ability. When grown in soft agar assays, the
Fig. 2 Expression of Somatostatin and its receptors in HT29 and SW480 colon cancer cell lines and patient matched normal and tumor tissue
samples. a Cells were grown to 70–80% confluency, RNA was isolated and RT-PCR was performed. The HT29 cells express SST, SSTR1, SSTR2, and
SSTR4. The SW480 cells express faint SSTR1, SSTR2, SSTR3, and SSTR4. This analysis was repeated three times and the gel images are representative
of one data set for each cell line. b RT-PCR was performed to look at mRNA levels of SST and SSTR1-5 in these 5 patient samples. In all the normal
samples, SST and SSTR1 were expressed. However, in the matching tumor samples, SST expression was gone and SSTR1 was present in 4 out of
5samples. N1 and T1 =matched normal and tumor tissue of patient #1. c Sorted ALDH+ and ALDH- cells from SW480 and HT29 cell lines were
analyzed for mRNA expression of somatostatin and its receptors. RT-PCR analysis was performed on ALDH- and ALDH+ cells. These results indicate
that the ALDH+ cells do not co-express somatostatin or its receptors in either cell line
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SW480 cells gave rise to spheres that were significantly
smaller in size than spheres that grew from the HT29
cells which were significantly larger in size (Fig. 3b).
Thus, similar to the proliferation rate, the sphere-
forming ability appears to inversely correlate with the
ALDH/SSTR1 quotient.
Treatment of CRC cell lines with somatostatin
Because our results showed that the cell lines express
SSTR1 and have different growth properties, we also
wanted to test for their responsiveness to activating ligand.
Accordingly, HT29 and SW480 cells were treated with
somatostatin (SST). We first did a dose response curve of
SST for each cell line (Additional file 2: Figure S2). The
cell lines were then treated with exogenous somatostatin
for 48 h and changes in ALDH+ cells, total cell numbers,
cell viability and sphere formation were analyzed. The
SST treatment decreased cell proliferation ~20% in both
HT29 and SW480 (Fig. 4b). The HT29 cells exhibited no
significant changes in ALDH+ cells, as analyzed by ALDH
activity, as well as, no significant changes in cell viability
or sphere formation, as compared to the vehicle controls
(Fig. 4a-d). Similarly, exogenous somatostatin did not sig-
nificantly change the ALDH+ cells, cell viability or sphere
formation in SW480 cells (Fig. 4 a-d). All values shown in
the graphs represent the ratio of treated cells over the ap-
propriate control. Overall, somatostatin treatment on the
two CRC cell lines did not significantly change the ALDH
+ population size or self-renewal ability.
Treatment of CRC cell lines with
cyclosomatostatin
We further wanted to see if competitive inhibition of
somatostatin would change the percentage of ALDH+
cells in the CRC cells. The cell lines were then treated
with exogenous cyclosomatostatin for 48 h and changes
in ALDH+ cells, total cell numbers, cell viability and
sphere formation were analyzed. The HT29 cells exhib-
ited a significant decrease in ALDH+ cells, cell count
(50%) and sphere formation upon inhibition of somato-
statin signaling, without affecting cell viability (Fig. 4a-d.
Addition of the somatostatin inhibitor to the SW480 cells
caused a similar result with a significant decrease in the
percentage of ALDH+ cells, a decrease in sphere forma-
tion and in cell count (30%), without affecting cell viability
(Fig. 4 a-d). All values shown in the graphs represent the
ratio of treated cells over the appropriate control.
Co-culture of ALDH+ cells with SSTR1+ cells
To assess whether SSTR1+ cells might modulate the
growth of ALDH+ cells, ALDEFLUOR+ and SSTR1+
cells were sorted from HT29 colon cancer cell line and
plated in a 1:1 ratio and allowed to grow in normal
growth medium. After one week in standard tissue cul-
ture, cells were assessed for degree of culture conflu-
ence. And cells were trypsinized and analyzed for
percent ALDEFLUOR+ cells. Results show that co-
cultures of ALDH+ cells and SSTR1+ cells have reduced
cell proliferation and an increased percentage of ALDE-
FLUOR positive cells (Additional file 4: Figure S4).
Next, we wanted to see if there is a paracrine effect of
SSTR1+ cells on ALDH+ cells. Both cell types were
sorted from HT29 and SW480 lines and co-cultured
under different conditions in ultra-low attachment
dishes with transwell inserts (0.4 um). ALDH+ cells
grown in the presence of signaling via SSTR1+ cells
(with or without exogenous somatostatin) significantly
decreased the size of spheres formed from the HT29
Fig. 3 Increased proliferation rate and self-renewal ability of HT29
cells over SW480 cells. a Growth of colon cancer cell lines under
normal culture conditions. An equal number of cells per well were
plated and counted at days 0, 1, 3 and 5 with a hemocytometer.
Dead cells were excluded by trypan blue analysis. Data represent
mean S.E.M. (N = 3). b These images represent a sphere formed from
a single cell, after two weeks in culture. Both images were taken
under bright field with a 10x objective lens, on the Zeiss Epi-
Fluorescence microscope. Quantification of spheres was done by
measuring the diameter of the spheres from random fields. Data
represents mean ± S.E.M. (N = 3)
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cells (Fig. 5a and c). Additionally, co-cultures of ALDH+
and SSTR1+ cells from the SW480 line showed a signifi-
cant decrease in both the number and sizes of spheres
(Fig. 5b and d). Thus, based on sphere formation, it ap-
pears that there is a paracrine effect of SSTR1+ cells on
ALDH+ cells from HT29 and SW480 cell lines.
Discussion
A more complete understanding of the effect of colonic
NECs on the SC population in the normal colon is crucial
to understanding SC function and cell proliferation and
will likely provide insight into the mechanism underlying
SC overpopulation that drives CRC growth. It is known
that somatostatin and SSTR expression is found in the
normal colon and SSTR1+ cells are located in close prox-
imity to SCs within the crypt SC niche (Additional file 1:
Figure S1) [5, 21]. Being in close proximity to each other,
we surmised that the interactions and communication be-
tween these cell types may be crucial to regulation of nor-
mal SCs. Research has shown that the SCs of the colonic
crypt are relatively quiescent as SC do not divide as rap-
idly as other cells in the epithelium and dysregulation of
the crypt homeostasis is what leads to CRC development
[2, 22]. Focus has been placed on different molecular fac-
tors involved in colonic SC regulation such as microRNAs
[23], transcription factors [24], and growth factors [25]
that can regulate SC function. However, we suggest that in
addition to such molecular factors, attention should be
placed on cellular mechanisms such as the cell-cell inter-
actions between NECs and SCs.
In our study, we first looked at the expression of ALDH
and SSTR1 in different CRC cell lines, as well as, in matched
normal and tumor tissue samples (Fig. 1). In addition, we
found that SSTR1+ cells from HT29 and SW480 cell lines
also express other neuroendocrine markers (Additional file
5: Figure S5). We observed differential expression of ALDH
and SSTR1 in the CRC cell lines and were able to identify
that in fact these markers identify two separate subpopula-
tions of cells found in human tissue samples and in CRC cell
lines. Next, we showed expression of mRNA encoding SST
and its receptors is present in matched normal and tumor
tissue samples (Fig. 2). Interestingly, SST was expressed in
all the normal tissue samples, but not expressed in the
matched tumor tissues. When we analyzed additional nor-
mal tissue samples (ones without matched tumor), the re-
sults still showed presence of SST expression in all samples
analyzed (data not shown). In addition, expression of SSTR1
was present in both primary normal and matched tumor
colon samples, as well as, in the normal only tissue samples
analyzed (data not shown). SST receptors have also been re-
ported to be differentially expressed in various tumor types
[26], and our data from different CRC tissue samples sup-
ports the expression of SSTR1 [27].
Next, the expression of SST mRNA and its receptors
was analyzed in the SW480 and HT29 CRC cell lines.
The results showed a trend similar to the pattern of
Fig. 4 Somatostatin treatment on HT29 and SW480 cells does not change the ALDH+ population size or self-renewal abilities but inhibition of
somatostatin decreases the ALDH+ population size. HT29 and SW480 cells were serum starved and then treated with 500 nM somatostatin or
cyclosomatostatin for 48 h. Cells were trypsinized and analyzed for changes in ALDH positive cells, cell numbers, and cell viability. Somatostatin
treatment did not significantly change the percentage of ALDH positive cells in either cell line for the number of ALDH positive cells (a), cell number
(b), or cell viability (c), as compared to the control untreated cells. Cyclosomatostatin decreased the percentage of ALDH positive cells in both cells
lines and only the cell number in HT29 cells, as compared to the controls. Data points represent the mean average values of treated cells over the
controls (N = 3) * p≤ 0.05. HT29 and SW480 cells were plated in ultra low attachment 6-well plates for colonosphere assay comparing untreated cells
to somatostatin and cyclosomatostatin treatments, After 10 days, the number of spheres per well were counted and average numbers per well were
calculated. Data points represent the mean average values of treated cells over the controls (d). SST = Somatostatin and CycloSST = Cyclosomatostatin
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expression in normal and tumor tissue samples. The
HT29 cells, which were originally derived from a low
grade, well-differentiated tumor, expressed SST and all
five of its receptors, but the SW480 cells, which were
originally derived from a high grade undifferentiated
tumor, did not express SST or SSTR5. Of note, at the
protein level, SSTR1+ cells were expressed in all CRC
cell lines and normal and tumor colon tissue samples.
That SST and SSTR1 were always expressed in the nor-
mal colonic epithelial cells, and SST was completely lost
in the tumor cells while SSTR1 was also expressed in
the tumor cells of some patients is an important finding.
Interestingly, a recent study similarly reported that SST
expression is lost in CRC yet expressed in the normal
colonic epithelium, thus supporting our findings [28].
Along with identifying the presence of ALDH+ and
SSTR1+ subpopulations in the CRC cell lines and hu-
man tissue samples, we tested the growth abilities of
HT29 and SW480 cell lines in terms of cell proliferation
and self-renewal. A major aim of this study was to study
the “stemness” characteristics of the HT29 and SW480
cells relative to the proportion of ALDH+ and SSTR1+
cells. Accordingly, several CRC cell lines were screened
that were originally derived from CRCs having differ-
ences in histological grade, stage and differentiation.
Within the CRC cell lines, we predicted that the relative
proportion of ALDH and SSTR1+ cells in any given cell
line will correlate with a certain rate of cell proliferation
and self-renewal. Therefore, the CRC cell line that has a
higher proportion of ALDH is predicted to show more
characteristics of “stemness” (slower proliferation and
smaller spheres). First, we obtained the cell proliferation
rate of various cell lines over a five day time course. Our
data on the in vitro growth of the cell lines showed that
the proliferation rate inversely correlates with ALDH/
SSTR1 quotient (Fig. 3). For example, HT29 cells (hav-
ing a low ALDH/SSTR1 quotient) had the fastest growth
rate (doubling time of 2.5d), while the SW480 cells (hav-
ing a high ALDH/SSTR1 quotient) the slowest growth
rate (doubling time of 4d).
The next step was to assess the ability to self-renew
and form spheres from single cells embedded in soft
agar. Our study showed the HT29 cells with a lower
proportion of ALDH+ cells formed fewer but larger
sized spheres than the SW480 cells (Fig. 3). This could
be due to the fact that sphere formation assays measure
the ability of a single SC to form many cells in culture
[20, 29] so the more SCs in a culture the more spheres
are formed. However, the difference between the sizes of
the spheres could be due to the proliferation rate of the
cell lines and the non-SC daughters with a faster doub-
ling time could give rise to larger sized spheres. Our data
indicates that the cell line with relatively more ALDH
cells (SW480) showed more features of true quiescent-
like SCs in terms of slower cell proliferation and
smaller-sized spheres. On the other hand, the cell line
Fig. 5 SSTR1 cell signaling limits sphere formation and cell proliferation of ALDH positive cells. ALDH positive cells were cultured in low
attachment dishes for colonosphere assay under various conditions with or without exogenous SST for HT29 (a and c) and SW480 (b and d) cells.
These experiments were all done in duplicate, * p ≤ 0.05. SST = Somatostatin and CycloSST = Cyclosomatostatin
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with fewer ALDH+ cells (HT29) showed more features
of transit amplifying or progenitor cells with a signifi-
cantly higher proliferation rate and large-sized spheres.
That each CRC cell line has a unique ALDH+/SSTR1+
ratio that is maintained constant over multiple passages
and that correlates with its growth dynamics in terms of
proliferation and sphere-forming ability, suggests feedback
mechanisms exist between ALDH+ and SSTR1+ cells that
contribute to regulation of the ALDH+ population size.
To further explore the role of SST and its signaling via
SSTR1 receptor, we chose to treat HT29 and SW480 cell
lines with exogenous SST with the goal of understanding
the effect on the ALDH population size. Already know-
ing the baseline proportions of ALDH+ to SSTR1+ cells,
we could feasibly measure the changes to the ALDH+
population due to enhanced SSTR1 signaling. SST is a
known to have anti-proliferative effects in normal divid-
ing cells like intestinal mucosal [5] yet the mechanism
involved is not well understood. SST can bind to all five
SST receptors subtypes and exert its effects of anti-
proliferation or secretion inhibition [5, 30, 31]. The dose
of SST was determined using a concentration range of
SST that is close to physiological levels. In treatment of
both HT29 and SW480 cell lines with exogenous SST, it
did not affect the ALDH population size in either line
(Fig. 4). The fact that SST treatments did not change the
ALDH population size or viability while decreasing pro-
liferation (Fig. 4a-c) could be a result of prolonged cell
cycle progression or delayed maturation.
On the other hand, the addition of cyclosomatostatin,
a somatostatin receptor antagonist, to the SW480 and
HT29 cells showed that when SST signaling was
blocked, there was a significant decrease in the ALDH+
population in both cell lines. There was also a decrease
in cell number after treatment, but no loss in cell viabil-
ity. Given that upon inhibition of SSTR1 signaling, there
is a significant decrease in the ALDH+ cell numbers, it
seems that an appropriate level of SST and SSTR1 sig-
naling is needed to maintain the ALDH+ cells in a
slower cycling state and any more or less SSTR1 signal-
ing can cause a significant change in the ALDH+ popu-
lation size. Thus, results from both SST and cycloSST
treatment suggests that just the right amount of SST sig-
naling is necessary for maintenance of ALDH+ cells and
generation of its proliferative progeny cell population.
Another important function of NECs in general is their
ability to signal through paracrine or autocrine mecha-
nisms [26]. To determine if SSTR1+ cell regulation of the
ALDH+ cells (Additional file 4: Figure S4) might occur via
paracrine signaling, we designed experiments in which
ALDH+ and SSTR1+ cells were co-cultured in transwell
dishes to avoid their direct cell-to-cell contact. In the
HT29 cells, there were a reduced number of spheres
formed and a significant difference in the average sizes, as
compared to the co-cultures of ALDH+ cells with SSTR1
negative cells (Fig. 5a and c). In the SW480 cells, there
was a significant decrease in the size and number of
spheres formed between the ALDH+ and SSTR1 negative
cells, and ALDH+ and SSTR1+ cells (Fig. 5b and d).
HT29 cells are fast growing colon cancer cells that
contain few ALDH+ cells and more differentiated cell
types. In comparison, SW480 cells are more undifferen-
tiated and have a slower growth rate. Based on our data,
co-culturing of ALDH+ cells with SSTR1+ cells had dif-
ferent effects depending on the cell line studied. Since
HT29 cells have a faster growth rate (with a doubling
time of less than 24 h), the effect of the SSTR1+ cells on
ALDH+ cells was minimal. On the other hand, the effect
of SSTR1+ cells on ALDH+ cells from the SW480 line
exhibit a significant reduction in both sphere size and
number. SSTR1+ cells affected the growth of the ALDH
+ cells by limiting the number of spheres and size of
spheres formed.
Collectively, our results indicate that SSTR1+ cells have
a paracrine signaling type of interaction with colonic
ALDH+ cells. Through our co-culture studies, there ap-
pears to be paracrine-mediated regulation via SSTR1+
cells to maintain the ALDH population size in a state of
quiescence, leading to slower cell cycling. Since ALDH+
cells lack SST and SSTR1 expression and the ALDH nega-
tive cell population cells expressed both SST and SSTR1,
we conjecture that SST signaling auto-regulates the rate of
NEC maturation in a feedback manner as SCs mature
along the NEC lineage, which contributes to quiescence of
SCs and inhibition of proliferation.
Conclusion
In summary, this study identifies a new role for SSTR1 cell
signaling in regulation of colonic ALDH+ cells. The fact
that the CRC cell lines each maintain a unique proportion
of ALDH+ and SSTR1+ cells over time, we surmised these
proportions are maintained constant through feedback
mechanisms involving ALDH and SSTR1 cell subpopula-
tions. Given that both SST and cycloSST produce growth
suppressive effects suggests that SST signaling modulates
this feedback mechanism. Moreover, the ability of SSTR1+
cells to decrease sphere formation and proliferation of
ALDH+ cells in transwell cultures indicates that the
ALDH subpopulation is regulated by SSTR1 via a para-
crine mechanism. Since ALDH+ cells lack SST and SSTR1
expression, we conjecture that SST signaling controls the
rate of SSTR1 NEC maturation as ALDH+ cells mature
along the NEC lineage, which contributes to quiescence of
ALDH+ cells and inhibition of proliferation. Our findings
may have clinical significance since modulating the quies-
cent state of SCs could make them more susceptible to
certain SC-targeted therapeutics designed to either differ-
entiate SCs or induce their apoptosis.
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Additional files
Additional file 1: Figure S1. Representative images of normal human
colonic crypts to show positive ALDH1 and SSTR1cells. These images are
a representative immunostaining of patient normal colon tissue sections
that stained positive for ALDH1 (1:100, BD Biosciences) and SSTR1 (1:100,
Advanced Targeting System). Both of these cell markers are expressed in
the normal colonic crypts. Images taken on the Zeiss Epi-Fluorescence
microscope or Zeiss 780 Confocal microscope and using the 20x
objective. (JPG 22 kb)
Additional file 2: Figure S2. Dose response curves for concentrations
of somatostatin in HT29 and SW480 cells. This data is based on the
counting of HT29 cells and SW480 cells after 48 h of treatment. Cells
were plated at 250,000 cells/well of a 6-well dish, allowed to attach
overnight and then serum starved for 24 h. Increased concentrations of
somatostatin were added to the cells and after 48 h cells were trypsinized
and counted. All cell counts were greater than 95% viable, which was
determined by trypan blue exclusion on the cell counter. Experiment was
done in triplicate and error bars represent ± SEM. (JPG 22 kb)
Additional file 3: Figure S3. Expression of ALDH positive cells via
ALDEFLUOR assay in SW480 and HT29 colon cancer cell lines. (A) The result
of the ALDEFLUOR assay performed on HT29 cells and imaged on the Zeiss
Epi-Fluorescence microscope before analyzed on the flow cytometer. (B)
The results of the ALDEFLUOR assay performed on SW480 cells and imaged
on the Zeiss Epi-Fluorescence microscope before analyzed on the flow
cytometer. Image was enhanced to show brightness of green color. Each
panel set shows the FITC channel for ALDEFLUOR positive cells and a bright
field image of all the cells. (JPG 28 kb)
Additional file 4: Figure S4. Co-cultures of ALDH+ cells and SSTR1+ cells
show decreased cell proliferation and an increased percentage of
ALDEFLUOR positive cells. ALDEFLUOR+ and SSTR1+ cells were sorted from
the HT29 colon cancer cell line and plated in a 6-well culture dish at a 1:1
ratio of each cell type and allowed to grow in normal growth medium.
Culture medium was changed every two days. Representative images were
taken after 7 days of co-culture (A) and then trypsinized and analyzed for
percent ALDEFLUOR positive (B). ALDH+ cells grown with SSTR1+ cells limit
the growth of the stem cells and keeps the cells more stem-like due to
increased percentage of ALDEFLUOR positive cells. (JPG 33 kb)
Additional file 5: Figure S5. Differential expression of neuroendocrine
markers in SSTR1+ cells from HT29 and SW480 cell lines. SSTR1+ cells
were sorted from the HT29 and SW480 colon cancer cell lines and RNA
was isolated. Conventional RT-PCR was performed on these samples to
show expression of other neuroendocrine markers co-expressed in the
sorted neuroendocrine cells, SSTR1+. In both cell lines, the SSTR1+ cell
population expresses the broad, widely accepted marker for
neuroendrocrine cells, CgA. The other neuroendorcrine markers are
differentially expressed between the two cell lines, as seen in the image.
CgA = Chromogranin A, NSE = enolase 2, NCAM = neural cell adhesion
molecule. (JPG 15 kb)
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